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Abstract: 
Background: The palatability of flucloxacillin oral liquid is poor. Parents/carers use strategies to aid 
administration of poorly palatable medicines.  
Aim: To assess views on the palatability of flucloxacillin oral liquid and identify factors associated 
with successful administration 
Methods: A mixed methods study which included a structured review of online forums and a survey 
of parent/carers of children with Cystic Fibrosis (CF) to obtain parent/carer views on the 
administration of flucloxacillin oral liquid. 
Results: 18 strategies to aid the administration of flucloxacillin suspension to children were 
identified on 10 different public online forums. 255 responses to the open online survey were 
received with 47% of respondents reporting that administration of flucloxacilin was more 
problematic compared to other medicines and 38% reporting the need to improve the palatability.  
The brand of flucloxacillin oral liquid significantly influenced the degree of difficulty associated with 
administration to children. A significant relationship was found between the concentration of 
flucloxacillin and the reported number of doses successfully administered. 
The use of food and drink to aid administration was more commonly stated in online forums (44%) 
compared to the survey data of parents/carers of children with CF (15.9%). 
Conclusion: Administration of flucloxacillin oral liquid is perceived as a challenge by parent/carers 
because of palatability.  For chronic use a more concentrated oral liquid and certain brands are likely 
to improve acceptability.  
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1. INTRODUCTION 
 
Poor palatability of paediatric medicines has the potential to influence adherence to therapeutic 
regimens and outcomes (1-3).  
Flucloxacillin was the second most commonly prescribed penicillin (following amoxicillin) within the 
UK in 2012 (4).UK guidelines recommend that babies with cystic fibrosis (CF), should be started on 
flucloxacillin (125mg twice daily) as antibiotic prophylaxis to prevent airway infection with 
Staphylococcus aureus (5). The current recommendations suggest this should be until the child is 
three years of age, although for most UK clinics the antibiotic is continued beyond this age. A trial in 
healthy child volunteers (conducted in the United States of America) reported that cloxacillin (similar 
tasting to flucloxacillin) tasted significantly worse than other antibiotics (6). It is widely reported 
amongst healthcare professionals that flucloxacillin is poorly palatable with recommendations that 
the child is observed swallowing a dose prior to full prescription (3, 7). Specific issues with 
flucloxacillin administration to children were identified by healthcare professionals in the UK, with 
one nurse suggesting giving a sweet (candy) after administration to improve acceptance (8). 
 
The extent to which dosage forms are manipulated to improve taste is unknown. Health 
professionals previously estimated that 10-30% of people modify their medicines (9). Mixing 
medicines with food is often undertaken in a paediatric setting to improve palatability, typical foods 
used within a hospital setting include jam, custard, yogurt, honey, juice and water (10). Data from 
parents suggest that up to 40% of medicines are mixed with food to improve palatability (11-13).  
Although mixing medicines into food/drink is common practice by parents and within paediatric 
wards,(14) there is no evidence base for this manipulation and  this is an area where further 
guidance is required (15).  Flucloxacillin stability is pH-dependent, with maximum stability at pH 6.5; 
and more rapid degradation at lower pH values (16). Therefore the pH of food mixed with 
flucloxacillin may affect its stability prior to ingestion. Mixing of flucloxacillin with food may impact 
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on drug stability and absorption, which may reduce efficacy. Sutherland et al (1970) reported a delay 
in the absorption of flucloxacillin and 50% overall reduction in the concentrations obtained following 
dosing adults in the fed state compared to the fasting state (17). Bergdahl et al (1986) conducted a 
study in children that compared the absorption of flucloxacillin in the fed and fasted state, the 
results did not show significant differences in the overall exposure (of the drug as a result of food in 
those aged 0.5-4 years however there appeared to be a significant (p<0.05) increase in the exposure 
in those aged 0-1 months in the presence of food, as well as a delay in the Tmax (18). The patient 
information leaflet for flucloxacillin states that it should be taken half to one hour before food (19-
21).  
 
A number of helpful websites have reported strategies to support parent/carers with administration 
of medicine to children (eg(22-24)). The information is not derived from a clear evidence base and it 
is difficult to translate this advice to specific populations or medicines (25).  
 
The aim of this study was to assess the extent to which palatability of flucloxacillin oral liquid is a 
barrier to administration and to compile resources to support parents/carers and improve 
administration of flucloxacillin oral liquid to children. Administration is linked to acceptability and 
often easing administration requires improving the acceptability of the medicine to the child. This 
study links improving acceptability to ease administration throughout. 
 
2. METHODS 
2.1. Review of online forums 
A systematic search of online forums was conducted using the search terms ‘flucloxacillin’ AND 
‘taste’ OR ‘palatability’ OR ‘child’ within a standard google.com search to identify reports of 
strategies used by parents/carers to aid administration of flucloxacillin to children. Online discussion 
forum websites were selected based on their popularity and common usage (by looking at the 
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number of users (where data was available) and the frequency of posts) by the UK population 
(rather than among specialist interest groups or social media superusers). This type of analysis is 
classified as passive analysis with low intrusiveness, that is, analysis of information patterns and 
interactions on discussion groups of which researchers have not been part. Information from these 
forums was extracted using a template to capture the age of the child; the reason for using 
flucloxacillin (acute vs chronic use); the reason why flucloxacillin administration was an issue; and 
the strategy employed by the parent/carer. The acute (treatment for infections)  vs chronic 
(prophylactic treatment) use was assessed by the original post to note the reason for prescribing 
flucloxacillin; where information was missing this was recorded as not-stated.  
 
2.2. Survey of parents/carers of children with CF 
Study design 
A bespoke survey was developed based on key questions that were identified by a multidisciplinary 
team (respiratory consultant; pharmacist; CF patient representative (adult); parent of a child with CF 
and academic researcher in paediatric medicines); relevant literature and the review of online 
forums to collect information on strategies that parents currently use or have used previously to aid 
in the administration of oral liquid flucloxacillin to children with CF.  
Participants and Recruitment 
For this survey, parent/carers of children with CF were identified as the target population; with 
inclusion criteria being that the survey participant identifies as caring for a child with CF who has 
taken oral liquid flucloxacillin (no exclusion criteria). Potential participants were recruited via 
distribution of the survey uniform resource identifier (URL) via 3-closed CF parent Facebook groups 
(total of 4840 members) and 2 open CF family Facebook groups (total of 1092 members). It was also 
shared on Twitter™ by the Cystic Fibrosis Trust (19000 followers) and CF Aware (10000 followers).  
Survey Development 
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The survey was constructed with fixed options as well as free text comments on questions to allow 
the best quality data to be generated whilst minimising the time burden to participants. Key areas of 
interest included: strategies used to administer oral liquid flucloxacillin based on the age of the child 
ranging from a pre-weaned child to an adolescent; the formulation of oral liquid flucloxacillin used 
(including brand and strength); the extent of the issue of administration of oral liquid flucloxacillin 
(compared to other medicines); the use of (i) food/drink (ii) devices and (iii) encouragement to aid in 
the administration of oral liquid flucloxacillin (with a request to include examples). A draft 
questionnaire was reviewed by the multidisciplinary team to assess ease of completion and ensure 
that questions were phrased unambiguously. The online survey software, Bristol Online Survey, 
(www.onlinesurveys.ac.uk ) was deemed most appropriate as it is specifically designed for academic 
research and public sector organisations and is fully compliant with UK data protection laws. A non-
probability based convenience sampling method was selected and individuals were left with a choice 
to “opt in” to the questionnaire following an invitation. A target sample size was not set as this was a 
consultation and not research therefore statistical powering is not relevant. However, it was felt that 
at least 200 responses were required to ensure that the results were representative. The survey 
used in this study was approved by the University of Birmingham Science, Technology, Engineering 
and Mathematics (STEM) Ethical Review Committee (reference ERN_14-1257). The questionnaire 
was launched on 3rd February 2015 with an end date of 3rd March 2015.The final survey is included 
as supplementary file 1.  
Data coding and analysis 
For closed-ended questions, questionnaire data was translated into numerical code on IBM SPSS 
statistical software package to allow the results to be analysed in order to assess the significance of 
patterns and relationships in the data (p<0.05 was the cut off for statistical significance). Cross-
tabulations and 2x2 tables were used to compare the relationship between questions, with non-
parametric chi-square tests being used to analyse the significance of relationships between 2 
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questions/variables; further, Cramer’s V coefficient was calculated to assess the strength of the 
association between the two variables.  
 
3. RESULTS 
3.1. Passive analysis of online forums 
Eighteen unique reports on the administration of flucloxacillin oral liquid were identified on 10 
different public online forums (Table 1). Details of the online forums included are listed in Box 1.  
Eight responses recommended mixing flucloxacillin with food/drink.  Milk was commonly used for 
children aged 6-20 months; honey, Nutella®, jam, ice cream and fruit flavoured drinks for those aged 
21-36 months. The use of an oral syringe to direct the medicine slowly into the back/side of the 
mouth was also reported as a method to ease administration compared to the medicine spoon 
supplied with the product. The use of rewards following administration of flucloxacillin was 
reported, with most being food-based. 
 
 
Table 1. Reports identified on public online forums to aid the administration of flucloxacillin to 
children  
 
The unpleasant taste of flucloxacillin was described in several forums, examples of such statements 
include:  
“It’s absolutely rancid and I don’t know why they offer it to young children” (Netmums contributor)  
“Floxapen brand of flucloxacillin actually tastes quite nice, it's the other unbranded stuff that's vile 
for some reason” (Damsels: the women’s network contributor) 
 
3.2. Survey responses from parents/carers of children with CF 
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255 responses to the questionnaire were received, 8 responses (3%) were received from outside of 
the UK. Only 2 respondents reported that their child had never previously taken and was not 
currently taking flucloxacillin oral liquid; their answers were removed from the analysis.  
 
47% of parents/carers reported the administration of flucloxacillin was more problematic than other 
medicines. Of those who answered ‘more’ (n=119), the majority (73.1%) of parents/carers reported 
that it was the taste of flucloxacillin which made it more difficult to administer. In addition, 30.2% of 
parents/carers answering ‘more’ stated that their child would spit out the medicine, retch or vomit. 
Administration was the greatest issue in pre-weaned children as shown in Table 2.  
 
Table 2. Impact of child’s age on the parents/carers response to ‘Compared to other medicines you 
have had to administer to your child, do you/did you find the administration of flucloxacillin more or 
less problematic?’  
 
 
llustrative quotes from parents regarding the impact of age on administration of flucloxacillin liquid 
are provided below, these quotes suggest that as the child gets older administration becomes less of 
an issue for children with CF. 
“Initially it was very, very difficult, however, my daughter eventually got used to it” (Participant 91) 
 
“Initially when our daughter was a tiny baby, it was by far the most difficult to give. She is now 3 and 
actually likes it though!” (Participant 12) 
 
“The taste was unbearable. I think he managed the sugar-free version in the end and I suppose after 
a year of administration he got used to the taste” (Participant 196) 
 
 
Chi-square analysis revealed a strong relationship between the responses to the question ‘To what 
extent do you agree with the statement ‘I find/found the administration of flucloxacillin 
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problematic?’ and ‘How many of the recommended doses of flucloxacillin do you/did you manage to 
successfully administer?’ (χ2= 78.5; p<0.001; Cramer’s V=0.40). The majority (89.3%) of 
parent/carers reported that they administer/administered ‘most doses’ or ‘all doses’ of flucloxacillin.  
There were 36 reports that a child spat out the medicine, retched or vomited which suggest over 
reporting of achieving most or all doses. The questionnaire did not define administration as 
swallowing the complete dose, therefore some parents may interpret administering all doses as 
providing them to the child yet not ensuring that the child swallowed the medicine.  
 
49% of respondents were unaware of the flucloxacillin brand that they administered to their child. A 
significant relationship was found between the brand of flucloxacillin administered and whether 
parents/carers agreed or disagreed with the statement 'I find/found the administration of 
flucloxacillin problematic' (χ2 = 11.2; p=0.047). Cramer’s V analysis implied a moderate association 
(V= 0.21) where parents/carers administering Crescent Pharma and Medreich brands were least 
likely to agree that flucloxacillin administration is problematic (data shown in figure 1). Some parents 
referred to Floxapen brand of flucloxacillin which was withdrawn in 2009 (29). A full list of brands 
available together with the flavouring agents used in each product is included in as supplementary 
material 2. 
  
Figure 1. The percentage of parents/carers for each brand of flucloxacillin administered reporting 
‘agree’ or ‘strongly agree’ in answer to the question, ‘To what extent do you agree with the 
statement 'I find/found the administration of flucloxacillin problematic'? 
 
A significant relationship was found between the concentration of oral liquid and the number of 
doses successfully administered (χ2 = 10.3; p=0.035). Only 6% of parents administering the stronger 
strength product (250mg/5mL) reported administering ‘no’ or ‘some doses’ in comparison with 12% 
of parent/carers administering 125mg/5mL. The increase in acceptability of the more concentrated 
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flucloxacillin product may be correlated with the increased age of the child as older children are 
more likely to be prescribed the stronger product, however, our data did not allow this analysis due 
to the sample size.  
Example quotes from parents are included to highlight these findings related to specific products. 
“Had the same brand for a while..child took it no bother..now it's this new one he's not too keen!!” 
(Participant 144) 
 
“It was the most problematic when she was on the lower strength, so therefore more {volume} and 
sugar-free. She now takes the 250mg/5ml normal (not sugar free) fine” (Participant 182) 
 
“Giving less with stronger strength and sticking with the sugar variety helped” (Participant 201) 
 
“My daughter is now on capsules she is 6 but taken capsules since aged 3” (Participant 34) 
 
 “Our hospital started my son on capsules before the age of 4 which has made things much easier” 
(Participant 77) 
 
16% of parent/carers reported that mixing with food/drink eased the administration of flucloxacillin. 
However a further 13% reported that mixing with food or drink did not help with administration. 
Furthermore, it was reported by 4% of parents/carers who had mixed with food/drink that the child 
would actually refuse to then consume the food or drink in the future. Chi-square analysis found a 
significant relationship between mixing with food/drink and whether the parents/carer found 
flucloxacillin administration problematic (χ2=22.7; p<0.001), with a strong relationship between the 
two (Cramer’s V=0.30). Based on the odds ratio, those who mixed with food/drink were 3.1 times 
more likely to describe administration as problematic. The different foods/drinks that were 
recommended changed with age where milk was used in pre-weaned babies and also being 
recommended for children up to 5 years old. In children aged 3-11, mixing with juice was popular, 
with hot chocolate also being described. Yoghurt was mentioned for all age groups that were 
weaned.  Illustrative quotes from parents/carers regarding the co-administration of flucloxacillin 
liquid with food or drink highlight common issues identified. 
“I tried to give with food, and even mix into drink, but it didn't help” (Participant 43) 
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“I give it while she's drinking her bottle as she sucks and takes it without realising but she's getting 
better at taking it straight from a syringe if in a good mood” (Participant 101) 
 
“We tried to mix with yoghurt. He now won't eat yoghurt because he thinks it tastes like that.” 
(Participant 121) 
 
“We were told by our nurse that it should not be added to milk or given with milk as that affected its 
potency. So we didn't do it.” (Participant 136) 
 
51% of parent/carers provided current/former strategies used to aid the administration of 
flucloxacillin oral liquid in pre-weaned babies. The most common strategy for pre-weaned babies 
was to use an oral syringe (and not the medicine spoon supplied); where flucloxacillin is 
administered slowly into the side or corner of the mouth. The use of a medicine dummy (soother 
medicine dispenser) and bottle teat were also described as strategies for the younger age groups. 
15.8% of parents/carers found that encouragement was helpful in the administration of flucloxacillin 
as children were older. The most commonly reported ways to encourage children to take 
flucloxacillin were praise (16.3% of parents/carers), sweets (16.3% of parents/carers) and stickers 
(12.7% of parents/carers). 
 
All survey participants were invited to provide any comments on how the administration of 
flucloxacillin could be improved and 162 of the 254 (64%) participants chose to respond. Table 3 
shows common themes. 
 
There were many negative comments made within this section, illustrated by, 
“..it’s very traumatic for a parent with a newly diagnosed (CF) child to have to deal with trying to 
force this (flucloxacillin) down their throat” (Participant 15) 
 
Table 3. Themed strategies reported to improve administration of flucloxacillin oral liquid (n=162 in 
total; n>5 was required for a topic to be considered a theme).  
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 Over a third (38.3%) of parents/carers in this study reported that they thought administration of 
flucloxacillin could be eased by a more pleasant taste or flavour. 11.1% parents/carers of children 
with CF recommended moving from the flucloxacillin oral liquid to capsules to avoid the issue with 
taste and 7 parents/carers reported children starting taking flucloxacillin capsules between 18 
months and 4 years of age.  
 
4. DISCUSSION 
Main Findings 
This study supports previous reports of the poor palatability of flucloxacillin oral liquid with several 
unprompted internet based reports of difficulties in administration to children and 34% of 
parent/carers of children with CF reporting that taste makes administration of flucloxacillin more 
problematic than other medicines. Online forum data revealed that administration issues were most 
common in children 3 years or younger; this was supported by findings from the survey of 
parents/carers of children with CF who identified that the issues around administration are greatest 
in the youngest children. The most problematic age group for the administration of flucloxacillin oral 
liquid was reported to be pre-weaned babies; therefore strategies to aid administration in this age 
group are likely to be particularly beneficial.   
 
Strengths and limitations 
This is the first study to collect data on parent/carer strategies on the delivery of flucloxacillin oral 
liquid to children. Online forums are useful sources of information regarding medicines 
administration although the authors recognise that only serious issues are likely to be raised and this 
may introduce some bias into the results. However, in identification of parent strategies in 
administration of flucloxacillin it is the responses to the originator post that are of most interest.  
The use of a survey to parents/carers of children with CF provided a means to gather data from a 
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population known to be experienced in the administration of flucloxacillin oral liquid to children; 
however, it is acknowledged that the survey used free text responses to explore the reasons why 
administration was problematic rather than quantifying all possible reasons. This approach was 
selected to minimise bias and allow parents/carers to provide information on all aspects of 
administration rather than being prompted by the use of potentially leading questions.  
It is acknowledged that parents/carers experiencing an issue with the administration of flucloxacillin 
are more likely to respond to a survey, however, as the results will be used to develop a support 
package for parents/carers that do experience an administration issue this population selection is 
appropriate. 
The use of an online survey provides wide reach into the CF population as it can be distributed easily 
and parents/carers have the option to opt in without pressure, however, it will only reach those 
parents/carers who are active in a CF social media network which was a recognised limitation of the 
study. This approach to distribution of the survey was selected as a link or message from an existing 
contact is typically less likely to be deleted or ignored. The distribution was centered around the UK 
CF population although the facebook groups and twitter accounts are open to other 
parents/carers/patients with CF globally, however, they are likely only to be accessed in English 
speaking countries. Although this was a qualitative study with nonprobability sampling techniques 
where the sample size is not critical, an estimate of the number of children with CF in the UK is 4500 
(Clinical guidelines: care of children with cystic fibrosis 2014); therefore the participants represent 
~5% of the total population within the UK. 
 
What is already known on this topic 
Previous reports of adherence to oral antibiotics are approximately 50% for four times daily dosing 
(as with flucloxacillin prescribed for acute infections) and ~70% for twice daily administration as in 
CF patients (26). However, there is evidence that parents over report compliance to medication (eg 
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(27, 28)). This study found that almost 90% of parents/carers reported administering all or most of 
the doses of oral liquid flucloxacillin to their child which is higher than previous reports. 
It is already known that nurses to use food/drink to mix with medicines within a ward setting (14) 
and there are previous reports of parents mixing medicines with food and drink with values of up to 
40% of medicines being mixed with food/drink (12, 13). The online forums primarily reported 
strategies used to aid administration of flucloxacillin oral liquid to children with an acute illness and 
the use of food as a co-administration aid to improve palatability was more common that reports 
from parents/carers of children with CF (a chronic illness).  However, although mixing medicines into 
food/drink is common practice there is no evidence base for this manipulation and that this is an 
area where further guidance would be beneficial as messages to parents/carers are often confusing 
and there is no evidence base to support co-administration of flucloxacillin with food (15). The lower 
incidence of using food as a co-administration aid in children with CF may be attributed to the 
comparative medicines related knowledge base of parents with a chronically ill child compared to 
those with a child with an acute illness. Further research is needed to evaluate the consequences of 
co-administration of flucloxacillin with food (15).  
Taste is one of the most common barriers to administration of medicines to children (3), this may be 
why the administration of flucloxacillin becomes easier with age, as the child can swallow a capsule 
which removes the issue of taste. The age at which children convert to capsules was not recorded in 
this study. The Summary of Product characteristics for flucloxacillin capsules does not have an age 
where these are considered appropriate, however, the minimum dose of 250mg suggests that this 
would only be appropriate for the treatment of certain children as, for example, the dose banding 
does not permit treatment for primary prevention of Staphylococcus aureus lung infection in cystic 
fibrosis (125mg twice daily).  
 
 
Implications for practice and recommendations 
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Information gathered from parents and carers on strategies to aid administration of oral liquid 
flucloxacillin to children can be used to advise other parents/carers on the administration of 
flucloxacillin and other poorly palatable medicines to children.  
The parent/carer recommendations within this study include: 
• The use of an oral syringe was commonly reported to improve issues around administration 
within the online forums; this is a standard medical device and is commonly used in the 
administration of liquid medicines to children; however, the ability to direct the medicine 
more accurately than using a spoon seems to be of benefit to children. Typically flucloxacillin 
is supplied with a spoon and not an oral syringe.  
• Using a higher strength product reduces the volume to be administered and this appears to 
have a beneficial impact on administration.  
• Certain brands were also highlighted as having fewer issues (Medreich and Crescent); 
however it is not clear why these brands are preferred. The flavours used in the more 
popular brands are pineapple and menthol in Medreich and cherry in Crescent; Actavis 
brand which was the least popular uses menthol, lemon and strawberry as flavouring agents 
and Milpharm another less popular brand uses pineapple and menthol (as Medreich) (full 
details of all formulations are included in supplementary file 2).  
• Parents faced with long-term administration should seek advice from their pharmacy with 
respect to identifying a preferred flucloxacillin brand and maintaining that supply. 
• Co-administration with food was reported to improve administration when flucloxacillin was 
indicated for the treatment of acute illnesses. However, it is not possible to provide any 
advice on foods that were more or less successful as the survey was not designed to answer 
this question. 
 
5. CONCLUSION 
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Administration of flucloxacillin oral liquid to children can be a challenge and parent/carers should be 
supported with this task. Previous knowledge of the impact of food on the bioavailability of 
flucloxacillin in children is not conclusive (18). Regular reports of mixing flucloxacillin with food 
highlights the need for additional research to understand the impact on pharmacokinetics of co-
administration with food to improve palatability rather than dosing with a full meal. These data 
demonstrate the need for production of more palatable paediatric formulations of flucloxacillin. It is 
important that manufacturers and regulators aid the development of more palatable medicines for 
children where possible. 
These data will facilitate the production of resources to support parents/carers in the administration 
of flucloxacillin (and other unpalatable medicines) highlighting the importance of a positive attitude; 
persistence; and specific strategies relating to the product brand and concentration. These resources 
may have important implications for the delivery of future clinical trials and to improve adherence to 
poorly palatable medicines used in paediatric practice. 
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Table 1. Reports identified on public online forums to aid the administration of flucloxacillin to 
children  
Patient Characteristics Strategy Reported 
Age of 
child 
(months) 
Treatment 
duration 
Mixed with 
food/drink 
Device 
used  
Reward  Other 
methods  
6 Chronic Milk       
6 Not stated   Syringe    Sing songs 
8 Acute    Dip syringe in 
Calpol® 
15 Not stated   Syringe    Pretend to 
give to pet 
15 Acute   Syringe  Fruit pastille    
20 Acute Formula milk       
20 Acute  Syringe    
21 Acute Honey       
22 Acute   Syringe      
24 Acute     Magic stars    
24 Acute Yoghurt, Nutella  Syringe      
24 Acute     Yoghurt   
36 Acute Jam, yoghurt, honey, 
fruit flavoured drink, 
Vimto 
Syringe      
36 Acute Calpol®, milk, sugar       
36 Acute Ice cream Syringe      
36 Acute Fruit flavoured drink   Chocolate 
fudge 
  
84 Acute       Drink of 
water after 
120 Acute     Sweets/fizzy 
drink 
  
 
Table 2. Impact of child’s age on the parents/carers response to ‘Compared to other medicines you 
have had to administer to your child, do you/did you find the administration of flucloxacillin more or 
less problematic?’  
 
 
 How problematic compared to other drugs (% of 
parents/ carers) 
n More Less No different 
Pre weaning  21 90.4 4.8 4.8 
Post weaning - 2 years  80 42.4 11.3 46.3 
3-5 years  68 50.0 13.2 36.8 
6-11 years  61 36.1 4.9 59.0 
12-17 years 23 43.5 17.4 39.1 
 
 
Table 3. Themed strategies reported to improve administration of flucloxacillin oral liquid (n=162 in 
total; n>5 was required for a topic to be considered a theme).  
 
Strategy Frequency 
Improve the taste/flavour of the product 62 
A positive parent/carer attitude 18 
Identify a favourite brand 13 
Use a sugar-containing brand 9 
Move onto the capsule product as soon as the child is able to swallow this product 18 
 
 
Figure 1. The percentage of parents/carers for each brand of flucloxacillin administered reporting 
‘agree’ or ‘strongly agree’ in answer to the question, ‘To what extent do you agree with the 
statement 'I find/found the administration of flucloxacillin problematic'? 
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Figure 2. Illustrative transcripts from parent/carers of children with CF on the use of food/drink to 
aid administration of flucloxacillin oral liquid. 
 
 
 
 
 
 
 
 
 
“I tried to give with food, and even mix into drink, but it didn't help” 
 
“I give it while she's drinking her bottle as she sucks and takes it without realising but she's 
getting better at taking it straight from a syringe if in a good mood” 
 
“We tried to mix with yoghurt. He now won't eat yoghurt because he thinks it tastes like 
that.” 
 
“We were told by our nurse that it should not be added to milk or given with milk as that 
affected its potency. So we didn't do it.” 
Figure 3. Illustrative transcripts from parents/carers of children with CF on the impact of age on 
administration of flucloxacillin oral liquid  
 
 
 
 
 
 
 
“Initially it was very, very difficult, however, my daughter eventually got used to it” 
 
“Initially when our daughter was a tiny baby, it was by far the most difficult to give. She is 
now 3 and actually likes it though!” 
 
“The taste was unbearable. I think he managed the sugar-free version in the end and I 
suppose after a year of administration he got used to the taste” 
 
Figure 4. Illustrative transcripts from parent/carers of children with CF on the impact of flucloxacillin 
oral liquid product on administration 
 
 
 
 
 
 
 
“Had the same brand for a while..child took it no bother..now it's this new one he's not too 
keen!!” 
 
“It was the most problematic when she was on the lower strength, so therefore more 
{volume} and sugar-free. She now takes the 250mg/5ml normal (not sugar free) fine” 
 
“Giving less with stronger strength and sticking with the sugar variety helped” 
 
“My daughter is now on capsules she is 6 but taken capsules since aged 3” 
 
 “Our hospital started my son on capsules before the age of 4 which has made things much 
easier” 
 
 
Box 1. Online forums included  
• Mumsnet (www.mumsnet.com) 
• Netdoctor (www.netdoctor.co.uk) 
• Netmums (www.netmums.com) 
• Bub Hub (www.bubhub.com) 
• Cystic Fibrosis Trust Forum (http://forum.cysticfibrosis.org.uk/ ) 
• Treasures (www.treasures.co.nz) 
• HealthUnlocked (www.healthunlocked.com) 
• BabyCentre (www.babycentre.co.uk) 
• Yahoo Answers (https://uk.answers.yahoo.com/) 
• Damsels: the women’s network (www.damsels.org)  
• Frightful Bish (https://frightfulbish.wordpress.com/)   
 
Supplementary file 1. Final survey distributed to parents/carers of children with CF. 
  
Question Answer options 
Please confirm whether you care/cared for a child with cystic 
fibrosis aged 17 or younger. 
 Yes/No 
Please confirm whether your child has previously taken/is 
currently taking liquid oral flucloxacillin? 
Yes/No 
Please select the age of your child. 
 
Pre weaning 
Post weaning- 2 years 
3-5 years 
6-11 years 
12-17 years 
Please identify the brand of flucloxacillin administered (the 
brand and/or concentration of the flucloxacillin will usually be 
printed on the box or the bottle). 
Actavis 
Aurobindo 
Milpharm 
I don’t know  
Other (please state) 
Please identify the strength of flucloxacillin administered 125mg/5mL 
250mg/5mL 
I don’t know 
Were you asked whether you would prefer one 
brand/concentration of flucloxacillin rather than another? 
If ‘yes’, please write whether you did or did not request a 
particular brand or concentration and give the reason(s) why. 
(Optional) 
Yes/No 
 
Free text 
 Compared to other medicines you have had to administer to 
your child, do you/did you find the administration of 
flucloxacillin more or less problematic? 
If you answered ‘more’, please briefly explain why in the box 
below 
More 
Less 
No different 
Free text 
To what extent do you agree with the statement ‘I find/found 
the administration of flucloxacillin problematic’? 
Strongly disagree 
Disagree 
Agree 
Strongly agree 
How many of the recommended doses of flucloxacillin do 
you/did you manage to successfully administer?  
No doses 
Some doses 
Most doses 
All doses 
To what extent do you agree with the statement ‘mixing 
flucloxacillin with food and/or drink eases/eased its 
administration’? 
Strongly disagree 
Disagree 
Agree 
Strongly agree 
Do you/did you ever use food or drink to aid in the 
administration of flucloxacillin?  
If you answered ‘yes’, please list any food and/or drink you 
have used in the box below with any additional comments or 
preferences. 
Yes/No 
 
Free text 
If your child is currently breast/bottle fed, what strategies do 
you use to aid the administration of flucloxacillin?  
Free text 
If your child is weaned, please give details in the box below of 
strategies you remember using to aid the administration of 
flucloxacillin when your child was still being breast/bottle fed 
(e.g. mixing with anything, what device worked best). 
(Optional) 
What delivery device do you/did you find most successful for 
the administration of flucloxacillin? 
Spoon 
Oral syringe into the side of mouth 
(cheek) 
Oral syringe into the back of the 
mouth  
Oral syringe onto the tongue 
Other (please specify) 
Do you/did you find encouragement (e.g. the use of sticker 
charts or treats) useful in the administration of flucloxacillin? 
If you answered ‘yes’, please give details in the box below 
Yes/No 
 
Free text 
Please give any other comments or ideas about how the 
administration of flucloxacillin could be improved/eased.  
Free text 
 
 
Supplementary file 2. 
Oral liquid flucloxacillin products currently available in the UK. Presented information is from the 
Summary of Product Characteristics for each product. 
 
 
Medicine name Active 
Ingredient 
Flavouring Sweetening 
agent 
Company 
name 
Flucloxacillin 125mg/5ml and 
250mg/5ml Sugar-Free Powder for 
Oral Solution 
Flucloxacillin 
sodium 
Menthol, 
lemon, 
strawberry  
Sorbitol Actavis UK 
Ltd 
Flucloxacillin 125mg/5ml Oral solution Flucloxacillin 
sodium 
Pineapple, 
menthol  
Sucrose Milpharm 
Ltd 
Flucloxacillin 125mg/5ml Sugar-Free 
Powder for Oral Solution 
Flucloxacillin 
sodium 
Menthol, 
lemon, 
strawberry 
Sorbitol Actavis UK 
Ltd 
Flucloxacillin 250/5ml Sugar Free Oral 
Solution 
Flucloxacillin 
sodium 
Menthol, 
lemon, 
strawberry  
Sorbitol  Actavis UK 
Ltd 
Flucloxacillin 125mg/5mL Powder for 
Oral Solution  
Flucloxacillin 
sodium  
Pineapple, 
Menthol  
Sucrose Medreich 
PLC 
Flucloxacillin 125 mg/5ml Granules for 
Oral Solution 
Flucloxacillin 
sodium 
Cherry  Sucrose Crescent 
Pharma Ltd 
Flucloxacillin 250 mg/5ml Granules for 
Oral Solution 
Flucloxacillin 
sodium 
Cherry  Sucrose Crescent 
Pharma Ltd 
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Supplementary file 3. 
Oral liquid flucloxacillin products currently available in the UK. Presented information is from the 
Summary of Product Characteristics for each product. 
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Company 
name 
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